Arizona House Bill HB2640

Arizona 2026 Regular Session

• Introduced: 1/20/26

Caption

fertilizer; PFAS; prohibition

Impact

The introduction of HB 2640 is poised to significantly impact state regulations under sections 3-264 and 3-283 of the Arizona Revised Statutes. It creates a framework for enforcing these new prohibitions, including stipulating that any distributor found violating these regulations may have their licenses canceled or denied. The bill provides the director of the regulatory body with broad enforcement powers, including the authority to determine penalties and address the composition of fertilizer materials to ensure compliance with safety standards. This could lead to increased scrutiny of commercial fertilizers across the state.

Summary

House Bill 2640 aims to amend existing legislation concerning fertilizer regulation in the state of Arizona, specifically by prohibiting the distribution and use of fertilizers that contain perfluoroalkyl and polyfluoroalkyl substances (PFAS). The bill is set to come into effect on December 31, 2027, effectively banning these fluorinated chemicals due to their detrimental effects on both human health and the environment. By targeting these substances, the bill seeks to enhance agricultural safety and protect public health from the risks associated with PFAS chemicals commonly found in commercial fertilizers.

Contention

While the bill is largely supported by environmental advocacy groups and public health organizations, it may face pushback from certain agricultural businesses that rely on fertilizers containing these substances. Concerns could arise regarding the economic impacts on farmers and distributors as they adapt to the new regulations that limit their options for fertilizer products. There may be debates on the balance between agricultural productivity and environmental safety, particularly questioning whether sufficient alternatives exist for farmers to transition to without compromising their yield or operational efficiency. The conflict between economic considerations and health standards persists as a central point of contention surrounding the bill.